Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Journal of Medical Virology|March 1, 2019
Switching to tenofovir disoproxil fumarate vs continuing treatment in patients with chronic hepatitis B who maintain long-term virological response to entecavir therapy: A randomized trialAyako Iida-Ueno, Masaru Enomoto, Ritsuzo Kozuka, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 29, 2013
Combination therapy of natural human interferon-beta and ribavirin for chronic hepatitis C patients with injection drug useHiroyasu Morikawa, Ritsuzo Kozuka, Hideki Fujii, et al.Internal Medicine (Tokyo, Japan)|May 24, 2021
Sofosbuvir/Velpatasvir Plus Ribavirin Combination Therapy for Patients with Hepatitis C Virus Genotype 1a, 2a, or 3b after Glecaprevir/Pibrentasvir Therapy FailedAyami Nonomura, Akihiro Tamori, Hoang Hai, et al.Journal of Medical Virology|September 17, 2020
Outcome of nucleos(t)ide analog intervention in patients with preventive or on-demand therapy for hepatitis B virus reactivationAkihiro Tamori, Kiminori Kimura, Kiyohide Kioka, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 18, 2015
Long-Term Outcome of Sequential Therapy with Lamivudine Followed by Interferon-β in Nucleoside-Naive, Hepatitis B e-Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C InfectionMasaru Enomoto, Shuhei Nishiguchi, Akihiro Tamori, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 8, 2012
Changes in sequences of core region, interferon sensitivity-determining region and interferon and ribavirin resistance-determining region of hepatitis C virus genotype 1 during interferon-alpha and ribavirin therapy, and efficacy of retreatmentRitsuzo Kozuka, Masaru Enomoto, Hoang Hai, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 10, 2018
Sequential therapy involving an early switch from entecavir to pegylated interferon-α in Japanese patients with chronic hepatitis BMasaru Enomoto, Shuhei Nishiguchi, Akihiro Tamori, et al.Cancers|February 27, 2026
12-Hydroxyheptadecatrienoic Acid Predicts Hepatocellular Carcinoma Development During Nucleos(t)ide Analogue TherapyHiroko Ikenaga, Ritsuzo Kozuka, Kirara Inoue, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 7, 2024
Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapyRitsuzo Kozuka, Masaru Enomoto, Yoshimi Yukawa-Muto, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|October 26, 2020
High dropout rate from aftercare program of antihepatitis C therapy for patients with history of injection drug useAkihiro Tamori, Sawako Uchida-Kobayashi, Ritsuzo Kozuka, et al.Pageof 6